Conditions: Overactive Bladder in Parkinson's Disease
Keywords: Overactive bladder Urinary incontinence Urinary frequency Parkinson's disease
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 23
Healthy volunteers: no

Brief summary:
This study will assess the effectiveness of solifenacin succinate (VESIcare) in reducing symptoms of overactive bladder in Parkinson's disease (PD) patients.

Detailed description:

Arms:
arm 1: None arm 2: None

Interventions: intervention 1: solifenacin succinate (VESIcare) intervention 2: placebo
Intervention descriptions: intervention 1: up to 10mg every day orally intervention 2: placebo matching solifenacin succinate (VESIcare) up to 10mg orally every day

Protocol document: